Yuxuan Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuxuan Sun has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Daiyun Chen
Department of Neurology, Tiantai People’s Hospital of Zhejiang Province (Tiantai Branch of Zhejiang Provincial People’s Hospital), Hangzhou Medical College, 317299 Taizhou, Zhejiang, China
1 shared publication - Fan Wu
Department of Neurology, Tiantai People’s Hospital of Zhejiang Province (Tiantai Branch of Zhejiang Provincial People’s Hospital), Hangzhou Medical College, 317299 Taizhou, Zhejiang, China
1 shared publication - Qian Gao
Department of Neurology, Tiantai People’s Hospital of Zhejiang Province (Tiantai Branch of Zhejiang Provincial People’s Hospital), Hangzhou Medical College, 317299 Taizhou, Zhejiang, China
1 shared publication - Yutong She
Department of Neurology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, 310009 Hangzhou, Zhejiang, China
1 shared publication
Latest Publications
- Open Access
- 20 March 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (3) , 52084
Reversal of Progressive In-Hospital Posterior Artery-to-Artery Embolic Stroke With Argatroban: A Case Report
Aims/Background: In-hospital progressive stroke in patients with pre-existing large artery occlusion presents a therapeutic dilemma, particularly when standard reperfusion strategies are unsuitable. This case report aims to illustrate a mechanism-guided medical approach in this complex scenario. Case Presentation: We report the case of a 65-year-old male patient with chronic left vertebral artery occlusion, hospitalised for dizziness, who experienced acute neurological deterioration with a National Institutes of Health Stroke Scale (NIHSS) score ranging from 2 to 14. Magnetic resonance imaging confirmed a new pontine infarction. Endovascular therapy was deferred due to suspected artery-to-artery embolism from an unstable plaque. Instead, argatroban infusion combined with antiplatelet therapy was initiated within 5 h. Results: The patient showed gradual improvement, and follow-up imaging demonstrated complete thrombus resolution. The NIHSS score was reduced to 4 at discharge. Conclusion: This case highlights the successful use of a mechanism-guided approach with argatroban for thrombolysis-naïve posterior circulation stroke, effectively balancing the thrombotic and haemorrhagic risks. This suggests that personalised anticoagulation may optimise outcomes in similar complex scenarios in which standard reperfusion is unsuitable.
- 20 March 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (3) , 52084
Open AccessReversal of Progressive In-Hospital Posterior Artery-to-Artery Embolic Stroke With Argatroban: A Case Report
Aims/Background: In-hospital progressive stroke in patients with pre-existing large artery occlusion presents a therapeutic dilemma, particularly when standard reperfusion strategies are unsuitable. This case report aims to illustrate a mechanism-guided medical approach in this complex scenario. Case Presentation: We report the case of a 65-year-old male patient with chronic left vertebral artery occlusion, hospitalised for dizziness, who experienced acute neurological deterioration with a National Institutes of Health Stroke Scale (NIHSS) score ranging from 2 to 14. Magnetic resonance imaging confirmed a new pontine infarction. Endovascular therapy was deferred due to suspected artery-to-artery embolism from an unstable plaque. Instead, argatroban infusion combined with antiplatelet therapy was initiated within 5 h. Results: The patient showed gradual improvement, and follow-up imaging demonstrated complete thrombus resolution. The NIHSS score was reduced to 4 at discharge. Conclusion: This case highlights the successful use of a mechanism-guided approach with argatroban for thrombolysis-naïve posterior circulation stroke, effectively balancing the thrombotic and haemorrhagic risks. This suggests that personalised anticoagulation may optimise outcomes in similar complex scenarios in which standard reperfusion is unsuitable.